BazEkon - Biblioteka Główna Uniwersytetu Ekonomicznego w Krakowie

BazEkon home page

Meny główne

Araja Diana (Ministry of Health,Republic of Latvia)
Experience of the Latvian Medicines Reimbursement System
Journal of Health Policy and Outcomes Research, 2013, nr 1, s. 58-63, tab., bibliogr. 3 poz.
Słowa kluczowe
System ochrony zdrowia, Finansowanie służby zdrowia, Finansowanie ochrony zdrowia
Health care system, Health care financing, Health care financing
In Latvia, the drug reimbursement system for outpatient treatment develops under limited resources. The reimbursement is performed against the degree of severity of certain diseases. The largest part of the health care budget recourses for the reimbursement system is allocated for groups of diagnoses 'Diseases of the circulatory system' (21.48% of total expenditures in 2012), 'Endocrine, nutritional und metabolic diseases' (20.44% of total expenditures in 2012) and 'Neoplasms' (14.60% of total expenditures in 2012). Taking into account the rapid growth of the reimbursement expenditures in 2011 as well as the patients' co-payment for non-reference medicinal products certain measures have been implemented such as refund, depending on the exceeded market share, which was implemented for the period of 2011-2012 and amounted to LVL 3.7million in 2011 and LVL 2million in 2012. The two-level tender system has been implemented since September 2011 for interchangeable medicinal products and for newly diagnosed patients only reference medicine is reimbursed by the NHS at the time of the first treatment. As the result of these activities with the increased number of patients an average price per prescription was reduced from LVL 15.30 in 2011 to LVL 14.43 in 2012 the expenditures per patient were reduced from LVL 157.38 in 2011 to LVL 145.63 in 2012. With the strictly limited state budget, a necessity to use additional possibilities to optimise the resource allocation for the health care program and prevention activities remain topical.(original abstract)
Pełny tekst
  1. Regulation No 899 of the Cabinet of Ministers of the Republic of Latvia "Procedures for the Reimbursement of Expenditures for the Acquisition of Medicinal Products and Medicinal Devices Intended for Out-patient Medical Treatment". Available from:
  2. News No.20 (2012) of the National Health Service. Available from:
  3. Unpublished statistical data of the National Health Service
Cytowane przez
Udostępnij na Facebooku Udostępnij na Twitterze Udostępnij na Google+ Udostępnij na Pinterest Udostępnij na LinkedIn Wyślij znajomemu